Boehringer Ingelheim Loses Fight Against Inflation Reduction Act
TL/DR –
A Connecticut federal court Judge has endorsed the Inflation Reduction Act’s process for negotiating Medicare drug prices, dismissing allegations of constitutional infringements. Large pharmaceutical companies have put forth similar arguments in other areas. However, these contentions have also been dismissed in jurisdictions such as New Jersey and Delaware.
Connecticut Federal Court Supports Medicare Drug Negotiation Process
The Inflation Reduction Act’s Medicare drug negotiation process has been given the green light by a federal court judge in Connecticut, dismissing allegations of constitutional violations.
This mirrors the trend in other jurisdictions like New Jersey and Delaware where similar challenges by prominent pharmaceutical companies have been rejected.
—
Read More US Economic News